[Recent advances of differentiation-inducing therapy for leukemia]

Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients.

Blood cancer journal·2013

New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.

Cancer gene therapy·2007

Establishment of a new human acute monocytic leukemia cell line TZ-1 with t(1;11)(p32;q23) and fusion gene MLL-EPS15.

Leukemia·2006

Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.

Cancer gene therapy·2005

Expression and sequence analyses of p33(ING1) gene in myeloid leukemia.

American journal of hematology·2002

Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist.

Planta medica·2001

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[DDX41-mutated myeloid neoplasms].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Clinical significance of germline pathogenic variants associated with hematologic malignancies].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Future directions in clinical development of first-line therapy for diffuse large B-cell lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[New developments in cord blood transplantation: immunological characteristics and strategies for relapse prevention].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

British journal of haematology·2026

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

British journal of haematology·2026

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Cancer cytopathology·2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Haematologica·2026

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Haematologica·2026

KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.

Haematologica·2026

Related Experiment Videos

[Recent advances of differentiation-inducing therapy for leukemia]

Related Concept Videos

Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients.

New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.

Establishment of a new human acute monocytic leukemia cell line TZ-1 with t(1;11)(p32;q23) and fusion gene MLL-EPS15.

Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.

Expression and sequence analyses of p33(ING1) gene in myeloid leukemia.

Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist.

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].

[DDX41-mutated myeloid neoplasms].

[Clinical significance of germline pathogenic variants associated with hematologic malignancies].

[Future directions in clinical development of first-line therapy for diffuse large B-cell lymphoma].

[Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse].

[New developments in cord blood transplantation: immunological characteristics and strategies for relapse prevention].

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.

Related Experiment Videos

[Recent advances of differentiation-inducing therapy for leukemia]

Related Concept Videos

Related Articles